Extracorporeal photochemotherapy as a challenging treatment for cutaneous T-cell lymphoma, acute and chronic graft-versus-host disease, organ rejection and T-lymphocyte-mediated autoimmune diseases

Transfusion Medicine and Hemotherapy

Volumn 35, Issue 1, 2008, Pages 8-17

  Perseghin, P ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b Ospedale San Gerardo de Tintori ^*  (Italy)

Author keywords

Autoimmune diseases; Cutaneous T cell lymphoma; Extracorporeal photochemotherapy; Graft versus host disease; Photopheresis

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; BETA INTERFERON; IMMUNOSUPPRESSIVE AGENT; METHOXSALEN; PENICILLAMINE; STEROID; UNCLASSIFIED DRUG; UVADEX;

ACUTE GRAFT VERSUS HOST DISEASE; ADJUVANT THERAPY; AUTOIMMUNE DISEASE; CANCER STAGING; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER MALFUNCTION; CHILL; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; DEVICE; DRUG ABSORPTION; DRUG FORMULATION; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; HUMAN; MONOTHERAPY; MULTIPLE SCLEROSIS; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SKIN DISEASE; T LYMPHOCYTE; TRANSFUSION; ULTRAVIOLET A RADIATION; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 39149139965     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111755     Document Type: Review

References (105)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G: Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303.
2. Parrish JA, Fitzpatrick TB, Tannembaum L, Pathak MA: Photochemotherapy of psoriasis with oral methoxalen and long wavelength ultraviolet light. N Engl J Med 1974;29:1207-1211.
3. Heald P, Rook A, Perez MI, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R: Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992;27:427-433.
4. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Witmer WK, Lazarus GS, Edelson R: Extracorporeal photochemotherapy for drug resistant pemphigus vulgaris. Ann Intern Med 1990;112:303-305.
5. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahalen MB, Varga J: Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992;128:337-346.
6. de Misa RF, Azana JM, Harto A, Ledo A: Extracorporeal photochemotherapy in the treatment of severe psoriatic arthropathy. Br J Dermatol 1992;127:448.
7. Menkes CJ, Andreu G, Heshmati F, Hilliquin P: Extracorporeal photochemotherapy Br J Rheumatol 1992;31:793-796.
8. Reinisch W, Nahavandi H, Santella R, Zhang Y, Gasche C, Moser G, Waldhor T, Gangl A, Vogelsang H, Knobler R: Extracorporeal photochemotherapy in patients with steroid dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther 2001;15:1313-1322.
9. Cavaletti G, Perseghin P, Dassi M, Cavarreta R, Frigo M, Caputo D, Stanzani L, Tagliabue E, Zoia C, Grimaldi M, Isella V, Rota S, Ferrarese C, Frattola L: Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis. Neurol Sci 2006;27:24-32.
10. Costanzo Nordin MR, Hubbel EA, O'Sullivan RJ, Johnson MR, Mullen GM, Heroux AL, Kao WG: Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Circulation 1992;86:242-250.
11. Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, Locatelli F, Argiolu F, Miniero R, Zacchello G: Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996;18(suppl 2):175-181.
12. Schooneman F: Extracorporeal photopheresis technical aspects. Transfus Apher Sci 2003;28:51-61.
13. Andreu G, Leon A, Heshmati F, Tod M, Menkes CJ, Baudelot J, Laroche L: Extracorporeal photochemotherapy (ECP): evaluation of two techniques and use in connective tissues disorders. Transfus Sci 1994;15:443-454.
14. Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giorgiani G, Del Fante C, Bergamaschi P, Maccario R, Pession A, Locatelli F: Extracorporeal photochemotherapy for the treatment of acute and chronic GVHD in childhood. Transfusion 2001;41:1299-1305.
15. Perseghin P, Dassi M, Balduzzi A, Rovelli A, Bonanomi S, Uderzo C: Mononuclear cell collection in patients undergoing extra-corporeal photochemotherapy for acute and chronic graft-vs-host disease (GvHD): comparison between COBE Spectra version 4.7 and 6.0 (AutoPBSC) J Clin Apher 2002;17:65-71.
16. Kanold J, Messina C, Halle P, Locatelli F, Lanino E, Cesaro S and Deméocq F, on behalf of the Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT): Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005;35:S69-S71.
17. Perseghin P, Galimberti S, Balduzzi A, Bonanomi S, Baldini V, Rovelli A, Dassi M, Rambaldi A, Castagna L, Corti P, Pogliani EM, Uderzo C: Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? Ther Apher Dial 2007;11:85-93.
18. Valbonesi M: International Forum: Italy. What's going on in Italy at the end of 2004. Transfus Apher Sci 2005;32:129-132.
19. Edelson RL: Transimmunization: science catches up to the clinical success. Transfus Apher Sci 2002;26:177-180.
20. Heshmati F: Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 2003;29:61-70.
21. Taylor A, Gasparro FP: Extracorporeal photochemotherapy for cutaneous T-cell lymphoma and other diseases. Semin Hematol 1992;29:132-141.
22. Bladon J, Taylor PC: Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999;107:707-711.
23. Tambur AR, Ortegel JW, Morales A, Klingeman H, Gebel HM, Tharp MD: Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 2000;32:747-748.
24. Bladon J, Taylor PC: Early reduction in the number of T cells producing pro-inflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc 2003;35:1328-1332.
25. Bladon J, Taylor PC: Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol 2002;146:59-68.
26. Bladon J, Taylor PC: Lymphocyte treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photoderm Photimmunol Photomed 2005;21:293-302.
27. Bladon J, Taylor PC: Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006;43:85-94.
28. Rigolio R, Perseghin P, Jonsson S, Petersson J, Cavaletti G, Cilio CM: A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system. J Photochem Photobiol (B) 2007;88:68-75.
29. Foss FM, Gorgun G, Miller KB: Extracorporeal photopheresis in chronic graft-versus-host diseases. Bone Marrow Transplant 2002;29:719-725.
30. Marshall SR: Technology insight: ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression? Nature Oncol 2006;3:302-314.
31. Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL: Transimmunization: a novel approach for tumor immunotherapy. Transfus Apher Sci 2002;26:205-216.
32. Zouboulis CC, Schmuth M, Doepfmer S, Dippel E, Orfanos CE: Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral blood CD4+ T lymphocytes. Dermatology 1998;196:305-308.
33. Di Renzo M, Rubegni P, De Aloe G, Paulesu L, Pasqui AL, Andreassi L, Auteri A, Fimiani M: Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous Tcell lymphoma. Immunology 1997;92:99-103.
34. Zeiser R, Marks R, Bertz H, Finke J: Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Ann Hematol 2004;83:551-565.
35. Vogelsang GB, Higman MA: Chronic graft versus host disease. Br J Haematol 2004;125:435-454.
36. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J: reduced frequency of FoxP3+ CD4+ CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106:2903-2911.
37. Hess AD: Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006;12:13-22.
38. Le NT, Chao N: Regulating regulatory T cells. Bone Marrow Transplant 2007;39:1-9.
39. Alcindor T, Gorgun G, Miller KB, Roberts TF, Sprague K, Schenkein DP, Foss FM: Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98:1622-1625.
40. Gorgun G, Miller KB, Foss FM: Immunologic mechanism of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002;100:941-947.
41. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo GF, Carsetti R: The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005;79:846-850.
42. Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A: Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+ CD25 +GITR+ FoxP3+ CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007;84:31-39.
43. Lim HW, Edelson RL: Photopheresis for the treatment of cutaneous T-cell Lymphoma. Hematol Oncol Clin North Am 1995;9:1117-1124.
44. Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, Bertani E: Photopheresis in cutaneous T-cell lymphoma: a five-year experience. Int J Artif Organs 2000;23:55-62.
45. Evans AV, Wood BP, Scarisbrick JJ, Fraser-Andrews EA, Chinn S, Dean A, Watkins P, Whittaker SJ, Russell-Jones R: Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictor of response. Blood 2001;98:1298-1301.
46. Knobler R, Jantschitsch C: Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfus Apher Sci 2003;28:81-89.
47. Schreiner T, Gaczkowski A, Scharffetter-Kocanek K, Borberg H: Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases. Transfus Apher Sci 2005;32:197-203.
48. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Wilmer WK, Lazarus GS, Edelson RL: Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990;112:303-305.
49. Gollnick HP, Owsianowski M, Taube KM, Orfanos CE: Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 1993;28:122-124.
50. Wollina U, Lange D, Looks A: Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999;198:140-144.
51. Gordon KB, Chan LS, Woodley DT. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997;136:415-420.
52. Bécherel PA, Bussel A, Chosidow O, Rabian C, Piette JC, Francès C: Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet 1998;351:805.
53. Sand M, Bechara FG, Sand D, Radenhausen M, Tomi NS, Altmeyer P, Hoffmann K: Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis. Dermatology 2007;215:134-138.
54. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello C, Cesaro S, Pillon M, Perotti C, Del Fante C, Faraci M, Rivabella L, Calore E, De Stefano P, Zecca M, Giorgiani G, Brugiolo A, Balduzzi A, Dini G, Zanesco L, Dall'Amico R: Extracorporeal photochemotherapy for paediatric patients with graft-versus-host diesease after haematopoietic stem cell transplantation. Br J Haematol 2003;122:118-127.
55. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F: Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002;100:1192-1200.
56. Owsianowsky M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE: Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994;14:845-848.
57. Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F: Extracorporeal photochemotherapy as single therapy for estensive, cutaneous chronic graft-versus-host disease. Transplantation 1995;59:149-151.
58. Schooneman F, Claise C: Treatment of graft versus host disease (GVHD) by photopheresis? Transfus Sci 1997;17:527-536.
59. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kahls P, Krutmann J, Hönigsmann H, Clovica M, Knobler RM: Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998;92:3098-3104.
60. Sniecinsky I: Photochemotherapy for GvHD. Int J Artif Organs 2000;1:1-10.
61. Perotti C, Torretta L, Viarengo G, Riveda L, Bernuzzi S, Carbone S, Del Fante C, La Torre R, Locatelli F, Sonetti F, Gabba P, Bellosta M, Salvaneschi L: Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 1999;84:237-241.
62. Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Deméocq F: Extracorporeal photochemotherapy for graft versus host disease in pediatric patients Transfus Apher Sci 2003;28:71-80.
63. Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P: Extracorporeal photopheresis therapy in the management of steroidrefractory or steroid-dependent cutaneous graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003;31:459-465.
64. Biagi E, Perseghin P, Buscemi F, Dassi M, Rovelli A, Balduzzi A: Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease. Haematologica 2000;85:329-330.
65. Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie K, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB: Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003;102:802-809.
66. Pavletic SZ, Lee SJ, Socie G, Vogelsang G: Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006;38:645-651.
67. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobson D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers MED, Greinix HT, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB: Measuring therapeutic response in chronic graft-versus-host disease: NIH consensus development project on criteria for clinical trials in chronic GvHD: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006;12:252-266.
68. Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB: Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005;35:1187-1193.
69. Couriel D, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu I, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M: Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GvHD. Blood 2006;107:3074-3080.
70. Garban F, Drillat P, Makowski C, Jacob MC, Richard MJ, Favrot M, Sotto JJ, Bensa JC, Cahn JY: Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica 2005;90:1096-1101.
71. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P, Mitterbauer M, Rabitsch W, Schulenburg A, Kahls P: The effect of intensified extracorporeal photochemotherapy on long term survival in patients with severe acute graft-versus-host disease. Haematologica 2006;91:405-408.
72. Lee SJ: New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005;105:4200-4206.
73. Rook A, Freundlich N, Nahass GT, Washko R, Macelis B, Skolnicki M, Bromley P, Witmer WK, Jegasothy BV: Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis. Yale J Biol Med 1989;62:639-645.
74. Rook A, Freundlich N, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Riestchel RL, Wintroub B, Bashar Kahaleh M, Varga J, Heald PW, Steen V, Massa MC, Murphy GF, Perniciaro C, Istfan M, Ballas SK, Edelson RL: Treatment of systemic sclerosis with extracorporeal photochemotherapy. Arch Dermatol 1992;128:337-346.
75. Zachariae H, Bjerring P, Heickendorff L, Møller B, Wallevik K, Angelo H: Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism. Acta Derm Venereol 1993;73:356-361.
76. Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I: Systemic sclerosis study group. A randomized double-blind, placebo controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006;54:793-799.
77. Malawista SE, Trock DH, Edelson RL: Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. Arthritis Rheum 1991;34:646-653.
78. Menkes CJ, Andreu G, Heshmati F, Hilliquin P: Treatment of refractory rheumatoid arthritis by extracorporeal photochemotherapy. Br J Rheumatol 1992;31:789-790.
79. Wilfert H, Honigsmann H, Steiner G, Smolen J, Wolff K: Treatment of psoriatic arthritis by extracorporeal photochemotherapy. Br J Dermatol 1990;122:225-232.
80. de Misa RF, Azana JM, Harto A, Boixeda P, Moreno L, Ledo A: Psoriatic arthritis: one year of treatment with extracorporeal photochemotherapy. J Am Acad Dermatol 1994;30:1037-1038.
81. Knobler RM, Graninger W, Lindmaier A: Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum 1992;35:319-324.
82. Hafler DA, Weiner HL: T cells in multiple sclerosis and inflammatory central nervous system disease. Immunol Rev 1987;100:307-332.
83. Wekerle H, Kojima K, Lannes V, Vieira J, Lassmann H, Limìnington C: Animal models. Ann Neurol 1994;36:47-53.
84. Poehlau D, Rieks M, Postert T, Westernhausen R, Busch S, Hoffmann K, Altmeyer P, Przuntek H: Photopheresis - a possible treatment of multiple sclerosis? Report of two cases. J Clin Apher 1997;12:154-155.
85. Rostami AM, Sater RA, Bird SJ, Galetta S, Farber RE, Kamoun M, Silberberg DH, Grossman RI, Pfohl D: A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult Scler 1999;5:198-203.
86. Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Lolli F, Riccio P, Tredici G, Frattola L: Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. J Neurol 2001;248:535-536.
87. Chabannes D, Besnier DP, Esnault VLM: Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat. Photodermatol Photoimmunol Photomed 2002;18:238-243.
88. Besnier DP, Chabannes D, Mussini JMG, Dupas B, Esnault VLM: Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study. Photodermatol Photoimmunol Photomed 2002;18:36-41.
89. Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L, Dalley CD, Snowden JA: Haemopoietic stem cell transplantation - an evolving treatment for severe autoimmune and inflammatory disease in rheumatology, neurology and gastroenterology. Hematology 2007;12:179-191.
90. Perez M, Edelson RL, Laroche L, Berger C: Inhibition of anti-skin allograft immunity by infusions with syngeneic photo-inactivated effector lymphocytes. J Invest Dermatol 1898;92:669-676.
91. Costanzo-Nordin MR, Hubbell E, O'Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, Kao WG, Mcmanus BM, Pifarre R, Robinson J: Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992:53:808-815.
92. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall'Amico R, Dorent R, Rogers JG, Radovanevic B, Taylor DO, Jeevanandam V, Marboe CC: Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med 1998;339:1744-1751.
93. Dall'Amico R, Murer L: Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Transfus Apher Sci 2002;26:197-204.
94. Sunder-Plassman G, Druml W, Steininger R, Hönigsmann H, Knobler R: Renal allograft rejection controlled by photopheresis. Lancet 1995:346:506.
95. Dall'Amico R, Murer L, Montini G, Andreetta B, Zanon GF, Zacchello G, Zacchello F: Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998;9:121-127.
96. Slovis BS, Loyd J, King LE: Photopheresis for chronic rejection of lung allografts. N Engl J Med 1995;332:962.
97. Salerno CT, Park SJ, Kreykes NS, Kulick DM, Savik K, Hertz MI, Bolmann RM: Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 1999;117:1063-1069.
98. Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER: Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 2000;5:44-47.
99. Astor TL, Weill D: Extracorporeal photopheresis in lung transplantation. J Cut Med Surg 2003;7:20-24.
100. Urbani L, Mazzoni A, Catalano G, De Simone P, Vanacore R, Pardi C, Bortoli M, Biancofiore G, Campani D, Perrone V, Mosca F, Scatena F, Filipponi F: The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Transplant Proc 2004;36:3068-3070.
101. Urbani L, Mazzoni A, De Simone P, Catalano G, Coletti L, Petruccelli L, Biancofiore G, Bindi L, Scatena F, Filipponi F: Avoiding calcineurin inhibitors in the early post-operative course in highrisk liver transplant recipients: the role of extracorporeal photopheresis. J Clin Apher 2007;22:187-194.
102. Berger C, Xu A, Hanlon D, Lee C, Schechner J, Glusac E, Christensen I, Snyder E, Holloway V, Tigelaar R, Edelson RL: Induction of human tumor-loaded dendritic cells. Int J Cancer 2001;91:438-447.
103. Girardi M, Schechner J, Glusac E, Berger C, Edelson RL: Transimmunization and the evolution of extracorporeal photochemotherapy. Transfus Apher Sci 2002;26:181-190.
104. Girardi M, Berger CL, Wilson LD, Christensen IR, Thompson KR, Glusac EJ, Edelson RL: Transimmunization for T cell lymphoma: a phase I study. Leuk Lymphoma 2006;47:1495-1503.
105. Bredberg A, Jonsson S, Lindblom A, Björk P: Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis. Photodermatol Photoimmunol Photomed 2007;23:113-119.